| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/17/2006 | US6987009 αgalactosidases and methods of using them |
| 01/17/2006 | US6987005 Where the human SNORF33 receptor has the amino acid sequence SEQ ID NO: 6; encoded by ATCC deposited plasmids; activated by either tyramine, tryptamine, or beta -phenyl-ethylamine; vectors; cells; membranes; nervous system disorders |
| 01/17/2006 | US6987002 Composition for detecting β-1,3-glucan |
| 01/17/2006 | US6987001 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents |
| 01/17/2006 | US6987000 Cardiac-related Ankyrin-Repeat Protein Kinase (CARK); useful as modulating agents for regulating cardiac cellular differentiation/proliferation |
| 01/17/2006 | US6986999 Test strip for determining dialysate composition |
| 01/17/2006 | US6986998 Assaying the components in very low-density lipoprotein fraction by an enzymatic reaction including reaction by enzyme showing a high specificity to VLDL carried out under the control by addition of calixarene or a salt thereof. |
| 01/17/2006 | US6986996 Using anti-heparanase antibody to bind heparanase encoded by amino acid sequence no.1 for monitoring heparanase protein expression of heparanase gene in white blood cells in vitro; drug delivery targets; diagnosis of tumors, cancer and metastasis |
| 01/17/2006 | US6986995 Methods of diagnosing liver fibrosis |
| 01/17/2006 | US6986992 P450 single nucleotide polymorphism biochip analysis |
| 01/17/2006 | US6986991 Detecting on the basis of chromosomes by amplifying nucleic acid of intestinal bacterial with a specific PCR primer; analyzing the pattern of an amplified fragment nucleic acid by fractionating by electrophoresis |
| 01/17/2006 | US6986990 Pollen allergy-related gene 513 |
| 01/17/2006 | US6986989 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 01/17/2006 | US6986988 Hybridization of cDNA obtained from sense RNA with cDNA obtained from antisense RNA, followed by DNA polymerase treatment of the sense-antisense hybrid DNA molecule; library generated by cloning of sense-antisense hybrid DNA in a vector |
| 01/17/2006 | US6986987 Genetic polymorphism in the receptor for IgA |
| 01/17/2006 | US6986986 subcloning nucleic acids encoding displayed polypeptides of enriched libraries from a display vector to an expression vector without the need for clonal isolation of individual members |
| 01/17/2006 | US6986985 Process for producing multiple nucleic acid copies in vivo using a protein-nucleic acid construct |
| 01/17/2006 | US6986869 Test strip for measuring analyte concentration over a broad range of sample volume |
| 01/17/2006 | US6986848 Using magnetically attractable particles; fast processing of a plurality of samples |
| 01/17/2006 | CA2374882C Molecular characterisation of chromosome translocation t(11;18)(q21;q21) and its correlation to carcinogenesis |
| 01/17/2006 | CA2138382C Alkaline phosphatase enzymes having improved specific activity for use in indicator reagents |
| 01/17/2006 | CA2086425C Fibroblast growth factor receptors |
| 01/16/2006 | CA2512295A1 Magnetic target entity separation method |
| 01/15/2006 | CA2471884A1 High oleic acid brassica juncea |
| 01/12/2006 | WO2006005081A2 Compositions and methods for identifying nucleotides in polynucleotide sequences |
| 01/12/2006 | WO2006005080A2 Method for detection of a nucleic acid sequence |
| 01/12/2006 | WO2006005074A2 Novel hot start nucleic acid amplification |
| 01/12/2006 | WO2006005054A2 System and methods for the management and treatment of vascular graft disease |
| 01/12/2006 | WO2006005042A2 Methods and compositions for the diagnosis,prognosis,and treatment of cancer |
| 01/12/2006 | WO2006005035A2 Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine pathways in lung cancer cells |
| 01/12/2006 | WO2006004949A1 Compositions and methods for detecting and quantitating polynucleotide sequences |
| 01/12/2006 | WO2006004939A2 Polymorphisms and haplotypes of the alpha 2c adrenergic receptor gene |
| 01/12/2006 | WO2006004936A2 Analysis of intracellular modifications |
| 01/12/2006 | WO2006004660A2 Detection of mutations in a gene associated with resistance to viral infection |
| 01/12/2006 | WO2006004611A2 Separation of nucleic acid |
| 01/12/2006 | WO2006004600A1 The importance of the gene hoxb13 for cancer |
| 01/12/2006 | WO2006004598A2 Proteomic analysis |
| 01/12/2006 | WO2006004549A1 ACETYL CoA CARBOXYLASE SPLICE VARIANT AND USES THEREOF |
| 01/12/2006 | WO2006004194A1 METHOD OF SCREENING REMEDY FOR ALZHEIMER’S DISEASE TARGETING TGF β2 |
| 01/12/2006 | WO2006003654A2 Methods and kits for predicting liver fibrosis progression rate in chronic hepatitis c patients |
| 01/12/2006 | WO2006003638A2 Novel method for labeling nucleic acid in a sequence-specific manner, and method for detecting nucleic acid using the same |
| 01/12/2006 | WO2006003526A2 Human autism susceptibility gene encoding otoa and uses thereof |
| 01/12/2006 | WO2006003523A2 Human autism susceptibility gene encoding prkcb1 and uses thereof |
| 01/12/2006 | WO2006003520A2 Human autism predisposition gene encoding a transcription factor and uses thereof |
| 01/12/2006 | WO2006003518A2 6-phosphorylcholine-n-acetyl-d-galactosamine conjugate molecules and their use in vaccinal, therapeutic and diagnostic applications against bacterial infection of the respiratory tract |
| 01/12/2006 | WO2006003439A2 Method for stabilising reagents which are useful for nucleic acid amplification |
| 01/12/2006 | WO2006003427A1 A protein involved in carcinoma |
| 01/12/2006 | WO2006003298A2 Method of determining the mutational load of a gene library obtained by random mutagenesis of a particular gene and means for implementing same |
| 01/12/2006 | WO2006002960A1 Instrument for efficient treatment of analytical devices |
| 01/12/2006 | WO2005118860A3 Compositions and methods related to an intestinal inflammation and uses therefor |
| 01/12/2006 | WO2005108605A3 Polymorphisms in abcb1 associated with a lack of clinical response to medicaments |
| 01/12/2006 | WO2005103295A3 Method and tools for analysis of nucleic acids |
| 01/12/2006 | WO2005100603A3 Tape stripping methods for analysis of skin disease and pathological skin state |
| 01/12/2006 | WO2005094332A3 Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators in non-small cell lung cancer |
| 01/12/2006 | WO2005090606A3 Identification of toxic nucleotide sequences |
| 01/12/2006 | WO2005082110A3 Haplotype markers for diagnosing susceptibility to immunological conditions |
| 01/12/2006 | WO2005069762A3 Bacillus licheniformis chromosome |
| 01/12/2006 | WO2005062760A3 Non-androgen dependent roles for androgen receptor and non-androgen related inhibitors of androgen receptor |
| 01/12/2006 | WO2005056836A3 Method for generating a predetermined amount of nucleic acid |
| 01/12/2006 | WO2005049652A3 Methods of generating antibody diversity in vitro |
| 01/12/2006 | WO2005039382A3 Prediction of likelihood of cancer recurrence |
| 01/12/2006 | WO2005025495A3 Methods and compositions for blocking progression of a disease state |
| 01/12/2006 | WO2005021718A3 Tubulin regulatory elements for use in plants |
| 01/12/2006 | WO2005017128A3 Improved reagents for recombinogenic engineering and uses thereof |
| 01/12/2006 | WO2005016287A3 Prkwnks as modifiers of the rac pathway and methods of use |
| 01/12/2006 | WO2005013809A3 Diagnostic and therapeutics for osteoporosis |
| 01/12/2006 | WO2005009203A3 Methods and compositions for use in diagnosing and characterizing diseases involving abnormal apoptosis |
| 01/12/2006 | WO2004106495A3 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| 01/12/2006 | WO2004099767A3 Biomolecular switching device using a holliday junction dna |
| 01/12/2006 | WO2004090108A3 Irna conjugates |
| 01/12/2006 | WO2004081194A3 Approaches to identifying genetic traits in animals |
| 01/12/2006 | WO2004081184A3 Markerless transformation |
| 01/12/2006 | WO2004078130A3 Posh interacting proteins and related methods |
| 01/12/2006 | WO2004067720A3 Systems and methods for predicting specific genetic loci that affect phenotypic traits |
| 01/12/2006 | WO2004032851A3 Screening and therapeutic methods relating to neurogenesis |
| 01/12/2006 | WO2004031354A3 Human sarcoma-associated antigens |
| 01/12/2006 | US20060010518 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
| 01/12/2006 | US20060010516 Cell cycle genes and related methods |
| 01/12/2006 | US20060010513 Oligonucleotide arrays to monitor gene expression and methods for making and using same |
| 01/12/2006 | US20060010506 Method for improving protein production |
| 01/12/2006 | US20060009916 Quantitative PCR data analysis system (QDAS) |
| 01/12/2006 | US20060009633 Complementary DNAs encoding proteins with signal peptides |
| 01/12/2006 | US20060009632 Nucleotide sequences coding metalloenzymes and/or aggrecanase for use in identifying modulators for prevention and treatment of bone disorders |
| 01/12/2006 | US20060009631 Nucleic acids encoding this enzyme; in humans, rodents; isotopes; purity; gene expression; transformation, translation of cells; sulfation of tyrosine; hybridization |
| 01/12/2006 | US20060009628 CONTAINING A 3-SUBSTITUTED PYRRAZOLO(,3,4-d) PYRIMIDINE |
| 01/12/2006 | US20060009621 For detecting a PMS2 protein, including a truncated PMS2, for detecting a predisposition to cancer, monoclonal antibody |
| 01/12/2006 | US20060009482 Screening method for identifying compounds that selectively induce interferon alpha |
| 01/12/2006 | US20060009470 Method for specifically potentiating N-type Ca2+ channel activity |
| 01/12/2006 | US20060009409 Double-stranded oligonucleotides |
| 01/12/2006 | US20060008911 Methods and compositions for regulating gene expression in plant cells |
| 01/12/2006 | US20060008889 Phosphatase specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative, autoimmune, muscular and graft vs. host diseases |
| 01/12/2006 | US20060008878 Monomeric red fluorescent proteins |
| 01/12/2006 | US20060008867 Microorganism culture medium |
| 01/12/2006 | US20060008866 Apparatus and method for detecting human fecal contamination on hands and other objects using an illumination imaging device |
| 01/12/2006 | US20060008865 Screening apparatus for water treatment with membranes |
| 01/12/2006 | US20060008864 Methods to measure compound specificity |
| 01/12/2006 | US20060008863 Electrochemical sensing using an enzyme electrode |
| 01/12/2006 | US20060008862 treating a disease associated with reduced activity of hexosaminidase (Tay Sachs disease and Sandhoff disease) by administering a compound selected from pyrimethamine and probucol |
| 01/12/2006 | US20060008861 Incorporation of anaerobic bacteria in feed formulation |
| 01/12/2006 | US20060008860 Reaction buffer; ATP extracting agents; at least 10 mM of a divalent cation (e.g., Mg2+, Ca2+ or Mn2+); at least 10 mM of divalent cation chelator; and optionally luciferase; gramnegative bacteria or yeast |